Cargando…

Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

INTRODUCTION: Cellular senescence is a hallmark of tumors and has potential for cancer therapy. Cellular senescence of tumor cells plays a role in tumor progression, and patient prognosis is related to the tumor microenvironment (TME). This study aimed to explore the predictive value of senescence-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yangyang, Cen, Kenan, Chen, Qiaoqiao, Dai, Ying, Mai, Yifeng, Hong, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902917/ https://www.ncbi.nlm.nih.gov/pubmed/36761753 http://dx.doi.org/10.3389/fimmu.2023.1128390

Ejemplares similares

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer
por: Cen, Kenan, et al.
Publicado: (2023)

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Construction of a neural network diagnostic model for renal fibrosis and investigation of immune infiltration characteristics
por: Guo, Yangyang, et al.
Publicado: (2023)

Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients
por: Cao, Jie, et al.
Publicado: (2023)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

Diagnostic model constructed by five EMT-related genes for renal fibrosis and reflecting the condition of immune-related cells
por: Guo, Yangyang, et al.
Publicado: (2023)

Identification and validation of novel biomarkers affecting bladder cancer immunotherapy via machine learning and its association with M2 macrophages
por: Wang, Junkang, et al.
Publicado: (2022)

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis
por: Lv, Yigang, et al.
Publicado: (2022)

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
por: Zhang, Heng-Chun, et al.
Publicado: (2022)

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
por: Song, Peng, et al.
Publicado: (2022)

MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients
por: Wang, Guilin, et al.
Publicado: (2022)

Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy
por: Xia, Minqi, et al.
Publicado: (2022)

Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma
por: Lu, Caibao, et al.
Publicado: (2022)

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy
por: Yao, Shijie, et al.
Publicado: (2023)

Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer
por: Zhou, Yanling, et al.
Publicado: (2022)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
por: Chen, Lin, et al.
Publicado: (2021)

A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma
por: Luo, Yi, et al.
Publicado: (2022)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
por: An, Bingzheng, et al.
Publicado: (2022)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
por: Wang, Zheng, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data
por: Gu, Xuyu, et al.
Publicado: (2023)

Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
por: Zhang, Zhao-Cong, et al.
Publicado: (2021)

Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer
por: Dai, Longfei, et al.
Publicado: (2022)

Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
por: Zheng, Xiaoyong, et al.
Publicado: (2022)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_702vt17k3g1k7ovajr1t870adc